Time-Restricted Feeding for the Prevention and Therapy of Lifestyle-dependent Disease
Not Applicable
- Conditions
- Prevention and therapy of lifestyle-dependent disease
- Registration Number
- DRKS00015057
- Lead Sponsor
- Institut für Allgemeinmedizin, Universität Ulm
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 104
Inclusion Criteria
Arm 1: Employees of the University/University Hospital Ulm, no known metabolic diseases, no known eating disorders.
Arm 2: Patients of the GP's practice with characteristics of metabolic syndrome without eating disorders, no insulin-dependent diabetes, no hyperthyroidism
Exclusion Criteria
Contraindications for fasting
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome measure is the achievement of the target period of 8-9 hours of food intake (recorded in a diary: time of first and last meal). For this purpose, the percentage of days with the achievement of the target over the entire study period is calculated for each participant.
- Secondary Outcome Measures
Name Time Method Secondary outcome measures are longitudinal changes in anthropometric parameters (height, weight, waist circumference) and laboratory parameters (fasting glucose, IGF-1, triglycerides, cholesterol, HDL, LDL, cortisol, LDH, CRP) as well as health-related quality of life (VAS from EQ-5D), sleep duration and quality. These data are collected at the two measurement points before and after the intervention.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie time-restricted feeding in preventing lifestyle-dependent diseases like obesity and diabetes?
How does time-restricted feeding compare to standard dietary interventions in managing metabolic syndrome and cardiovascular risk factors?
Which biomarkers are associated with response to time-restricted feeding in patients with insulin resistance and non-alcoholic fatty liver disease?
What are the potential adverse events of time-restricted feeding in long-term lifestyle disease management and how are they managed?
Are there combination approaches involving time-restricted feeding and pharmacological agents for treating type 2 diabetes and hypertension?